Huperzine B

CAS No. 103548-82-9

Huperzine B( —— )

Catalog No. M17768 CAS No. 103548-82-9

Huperzine-B is a efficient inhibitor of human brain AChE. Huperzine-B can enhance ognitive and protect neuro, may be potentially new drug candidates for Alzheimer's disease therapy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 132 In Stock
10MG 227 In Stock
25MG 429 In Stock
50MG 538 In Stock
100MG 767 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Huperzine B
  • Note
    Research use only, not for human use.
  • Brief Description
    Huperzine-B is a efficient inhibitor of human brain AChE. Huperzine-B can enhance ognitive and protect neuro, may be potentially new drug candidates for Alzheimer's disease therapy.
  • Description
    Huperzine-B is a efficient inhibitor of human brain AChE. Huperzine-B can enhance ognitive and protect neuro, may be potentially new drug candidates for Alzheimer's disease therapy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    103548-82-9
  • Formula Weight
    256.34
  • Molecular Formula
    C16H20N2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (97.53 mM)
  • SMILES
    CC1=CC2CC3=C(C=CC(=O)N3)C4(C1)C2CCCN4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Edotreotide

    Edotreotide gallium Ga-68 is an 8 amino acid peptide bound to the chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA).

  • Rutaevin 7-acetate

    Rutaevin 7-acetate is a natural product for research related to life sciences.

  • 5-Hydroxymethyl-2-fu...

    5-Hydroxymethyl-2-furancarboxylic acid (Sumiki's acid) is a naturally occurring human metabolite. Sumiki's acid was first identified in the urine of a leukemia patient who was excreting an abnormal amount of its glycine derivative. Sumiki's acid has been found to be a byproduct of the fungus Aspergillus and probably other species of fungi and yeast as well.